WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 14,490 shares, a growth of 86.4% from the September 30th total of 7,775 shares. Based on an average daily volume of 1,847 shares, the short-interest ratio is currently 7.8 days. Currently, 9.7% of the shares of the company are sold short.
WisdomTree BioRevolution Fund Stock Down 2.1%
WDNA stock opened at $23.61 on Tuesday. The company has a market cap of $3.54 million, a PE ratio of 17.03 and a beta of 1.01. The business has a 50-day simple moving average of $23.31 and a 200 day simple moving average of $19.81. WisdomTree BioRevolution Fund has a 52 week low of $15.67 and a 52 week high of $25.03.
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Further Reading
- Five stocks we like better than WisdomTree BioRevolution Fund
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
